Literature DB >> 21226861

Evaluation of cystatin C with iohexol clearance in cardiac surgery.

B Brondén1, A Eyjolfsson, S Blomquist, A Dardashti, P Ederoth, H Bjursten.   

Abstract

BACKGROUND: Post-operative renal dysfunction after cardiac surgery is not uncommon and can lead to adverse outcome. The ability to accurately monitor renal function is therefore important. Cystatin C is known to be a sensitive marker of the glomerular filtration rate (GFR), but it has not been fully evaluated in cardiac surgery. Iohexol clearance is considered a reliable reference method for the determination of GFR. The aim of this study is to, for the first time, evaluate the diagnostic accuracy of plasma cystatin C compared with iohexol clearance in cardiac surgery.
METHODS: Twenty-one patients scheduled for elective coronary artery bypass grafting were prospectively enrolled in the study. Before surgery and on the second post-operative day, an iohexol clearance was performed. Plasma cystatin C, plasma creatinine and plasma C-reactive protein were determined before surgery and on the first, second, third and fifth post-operative day. Estimated creatinine and cystatin C clearances were determined.
RESULTS: Post-operative cystatin C and 1/cystatin C correlated strongly to iohexol clearance (r=-0.90 and 0.86) and so did creatinine and 1/creatinine (r=-0.83 and 0.78). Estimated creatinine clearance differed from iohexol clearance (P<0.01), whereas estimated cystatin C clearance did not differ from iohexol clearance (P=0.81). No correlation was found between C-reactive protein and cystatin C.
CONCLUSION: This study indicates that clearance estimations based on cystatin C are more accurate compared with estimations based on creatinine in determining GFR in cardiac surgery. Cystatin C has, in this study population, a stronger correlation to iohexol clearance than creatinine.
© 2011 The Authors. Journal compilation © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226861     DOI: 10.1111/j.1399-6576.2010.02361.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurements.

Authors:  Nori J L Smeets; Esther M M Teunissen; Kim van der Velden; Maurice J P van der Burgh; Demi E Linders; Elodie Teesselink; Dirk-Jan A R Moes; Camilla Tøndel; Rob Ter Heine; Arno van Heijst; Michiel F Schreuder; Saskia N de Wildt
Journal:  Pediatr Nephrol       Date:  2022-08-02       Impact factor: 3.651

2.  Comparison of serum cystatin C and creatinine changes after cardiopulmonary bypass in patients with normal preoperative kidney function.

Authors:  Anders S Svensson; Csaba P Kovesdy; John-Peder Escobar Kvitting; Magnus Rosén; Ingemar Cederholm; Zoltán Szabó
Journal:  Int Urol Nephrol       Date:  2013-03-06       Impact factor: 2.370

3.  Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?

Authors:  Evelyn Dhont; Tatjana Van Der Heggen; Annick De Jaeger; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

4.  Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine.

Authors:  Pierre Delanaye; Etienne Cavalier; Jérôme Morel; Manolie Mehdi; Nicolas Maillard; Guillaume Claisse; Bernard Lambermont; Bernard E Dubois; Pierre Damas; Jean-Marie Krzesinski; Alexandre Lautrette; Christophe Mariat
Journal:  BMC Nephrol       Date:  2014-01-13       Impact factor: 2.388

5.  Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study.

Authors:  Matthias Thielmann; David Corteville; C David Mazer; Gabor Szabo; Madhav Swaminathan; Andre Lamy; Lukas J Lehner; Craig D Brown; Nicolas Noiseux; Mohamed G Atta; Elizabeth C Squiers; Shai Erlich; Daniel Rothenstein; Bruce Molitoris
Journal:  Circulation       Date:  2021-09-03       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.